Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

CVE-2022-26240

22
FAUCET Score

CVE-2022-26240 describes a privilege escalation vulnerability in Beckman Coulter Remisol Advance v2.0.12.1 and earlier, where non-privileged users can overwrite and manipulate executables and libraries due to default service privileges. This allows attackers to access sensitive data. Rated 6.5 MEDIUM, the vulnerability has a low attack complexity and requires low privileges to exploit, potentially leading to high confidentiality impact. There is currently no evidence of active exploitation, public exploit code, or significant community discussion surrounding this CVE.

Impacted Technologies

VendorProductVersion(s)CPE
<= 2.0.12.1CPE matchmatch criteria
cpe:2.3:a:beckmancoulter:remisol_advance:*:*:*:*:*:*:*:*

CVSS Data

CVSS version used by this source: 3.1

6.5MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
NONE
Availability Impact
NONE
Exploitability Score
2.8
Impact Score
3.6
CvssVersion
3.1

Exploit Intelligence

EPSS Score
0.59%
Probability of exploitation in next 30 days
EPSS Percentile
44.6%
Percentile rank of EPSS score among Peer Group
As of 2026-07-27
Model: v2026.06.15
This CVE's current EPSS score of 0.0059 is in the 55th percentile among its peer group of 21,977 CVEs.

Social Chatter

The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.1 Bluesky, 0.0 Mastodon, and 0.1 GitHub mentions.

Media Mentions

No media coverage found for this CVE.

The average CVE in this peer group has 0.0 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.

Remediation

Remediation records are not available for this CVE.

References

pastebin.com / Bsy6KTxJ
Third Party Advisory
beckmancoulter.com / products/clinical-information-management-tools/remisol-advance
Product